Sign in

NCT07016282Active, not recruiting

Simulated and Synthetic Health Data: Improving Clinical Research on Rare Diseases. A Real-World Data Simulation of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Trials. A Retrospective, Observational Study

Source: ClinicalTrials.gov · Last updated 2 Sept 2025

Brief summary (registry, in English)

This is a no-profit, retrospective observational study involving real-world data (RWD), retrieved from ADPKD-related electronic health records stored at Mario Negri Institute IRCCS. RWD will be used to generate simulated and synthetic datasets, using AI tools. RWD and generated data (GD) will be used to conduct three virtual RCTs, which main outcome is change in Total Kidney Volume (TKV). Statistical tests will be performed to assess quality and privacy preservation of GD compared with RWD. GD will be also evaluated in exploratory sample size estimations.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
27 May 2025
Start date
12 Jun 2025
Primary completion date
30 Jun 2027
Lead sponsor
Mario Negri Institute for Pharmacological Research
NCT number
NCT07016282

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 12 Jun 2025 to the primary completion date, 30 Jun 2027
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Abnormal urinalysis suggestive of concomitant, clinically significant glomerular disease, and urinary tract lithiasis or infection

Other illness

  • confounding factors that could affect renal function loss independent of kidney growth and treatment allocation (i.e., diabetes mellitus, urinary protein excretion rate \>3 g/24 h)
  • Patients with major systemic disease

Other

  • Patients unable to provide informed consent
  • Pregnant, lactating, or potentially childbearing women without adequate contraception

Who the study is looking for

  • Adult (\>18 years) men and women with ADPKD according to Ravine criteria25
  • Estimated glomerular filtration rate (eGFR) between 15 and 40 mL/min/1.73 m2 (CKD stage: G3b-G4) or higher (CKD stage: G1-G3a), as calculated by the Modification of Diet in Renal Disease study four variables equation

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Clinical Research Centre for Rare Diseases Aldo e Cele Daccò
Coordinator of this site? Confirm its status
RanicaItalyUnknown status
Department of Global Public Health (GPH), Karolinska Institutet
Coordinator of this site? Confirm its status
StockholmSwedenUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.